Sector

Healthcare

Region

AUM

178.36M

Fund Score

SPDR S&P Pharmaceuticals ETF (ARCA:XPH) Quotes, Forecast and News Summary

SPDR S&P Pharmaceuticals ETF (ARCA: XPH) stock price, news, charts, stock research, profile.

Open	$43.19
High	$43.97
52 Wk High	$48.76
AUM	178.36M
Dividend	$0.62
Ex-Div Date	Jun 24, 2024
Volume	58.36K
Market Cap	$77.80B
Mgmt Fee	0.35%
P/E Ratio	16.08
Prev. Close	$43.25
Low	$43.07
52 Wk Low	$38.88
Shares Out	4.85M
Yield	1.48%
Div. Freq	Quarterly
Avg. Volume Daily	50.77K
Beta	0.76
Avg. Expense Ratio	0.35%
P/B Ratio	-

Recent News

Pharma ETFs in Focus Post Solid Q2 Earnings

The second-quarter results of the healthcare sector have been impressive, with earnings of 78.8% of the sector participants that have reported so far up 17.1% on 7.6% revenue growth. The earnings beat ratio of 85.7% and the revenue beat ratio of 75.5% are also assuring.

Zacks

Purdue Pharma Bankruptcy Plan Rejected by Supreme Court, Billionaire Sacklers to Face Lawsuits

The Supreme Court has rejected Purdue Pharma's bankruptcy plan, exposing the Sackler family to lawsuits over their role in the opioid crisis. This decision impacts victims, state and local governments, and the broader use of bankruptcy in mass litigation.

Vandana Singh

A Look at Pharma ETFs Post Q1 Earnings

The first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of the sector participants that have reported so far down 31.2% despite 4.4% revenue growth. The earnings beat ratio of 93.9% and the revenue beat ratio of 75.8% are assuring, though.

Zacks

FAQ

How do I buy SPDR S&P Pharmaceuticals ETF (XPH) stock?

You can purchase shares of SPDR S&P Pharmaceuticals ETF (ARCA:XPH) through any online brokerage.

View our list of the best stock brokerages

Who are SPDR S&P Pharmaceuticals ETF (XPH) competitors?

There are no as such competitors for SPDR S&P Pharmaceuticals ETF.

What is the forecast, or price target, for SPDR S&P Pharmaceuticals ETF (XPH) stock?

There is no analysis for SPDR S&P Pharmaceuticals ETF to provide a consensus price target.

What is the current price for SPDR S&P Pharmaceuticals ETF (XPH)?

The stock price for SPDR S&P Pharmaceuticals ETF (ARCA: XPH) is $43.35 last updated December 19, 2024 at 4:31 PM EST.

Does SPDR S&P Pharmaceuticals ETF (XPH) pay a dividend?

A quarterly cash dividend of 0.05 per share of Class A Common Stock. The quarterly cash dividend was payable on September 27, 2018 to stockholders of record on September 24, 2018.

When is SPDR S&P Pharmaceuticals ETF (ARCA:XPH) reporting earnings?

SPDR S&P Pharmaceuticals ETF does not have any upcoming earnings scheduled.

Is SPDR S&P Pharmaceuticals ETF (XPH) going to split?

There is no upcoming split for SPDR S&P Pharmaceuticals ETF.

Open	$43.19
High	$43.97
52 Wk High	$48.76
AUM	178.36M
Dividend	$0.62
Ex-Div Date	Jun 24, 2024
Volume	58.36K
Market Cap	$77.80B
Mgmt Fee	0.35%
P/E Ratio	16.08
Prev. Close	$43.25
Low	$43.07
52 Wk Low	$38.88
Shares Out	4.85M
Yield	1.48%
Div. Freq	Quarterly
Avg. Volume Daily	50.77K
Beta	0.76
Avg. Expense Ratio	0.35%
P/B Ratio	-

ETF Details

Sector	Healthcare
Category	Mid Performer-Mid Growth
Investment Style	Mid Cap Blend
Fund Inception	Jun 19, 2006
Managers	Keith Richardson Karl A. Schneider
Definition	Most of the stocks in this Equity Fund have average financial performance and average growth potential

Investment Policy

In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index (S&P TMI).

Top ETF Holdings

Symbol	Name	Share %
AXSM	Axsome Therapeutics, I...	4.26%
VTRS	Viatris Inc.	4.26%
ITCI	Intra-Cellular Therapi...	4.17%
BMY	Bristol-Myers Squibb C...	4.15%
PFE	Pfizer, Inc.	3.98%
CORT	Corcept Therapeutics I...	3.94%
JNJ	Johnson & Johnson	3.90%
OGN	Organon & Co	3.85%
CTLT	Catalent, Inc.	3.84%
ZTS	Zoetis, Inc.	3.79%

Comments

SPDR S&P Pharmaceuticals ETF

Overview